Mechanical thrombectomy for large vessel occlusion between 6 and 24 h: outcome comparison of DEFUSE-3/DAWN eligible versus non-eligible patients.

Publikation

Mechanical thrombectomy for large vessel occlusion between 6 and 24 h: outcome comparison of DEFUSE-3/DAWN eligible versus non-eligible patients.

Wissenschaftlicher Artikel/Review - 14.12.2022

Dittrich Tolga, Sporns Peter B, Kriemler Lilian, Rudin Salome, Nguyen Anh, Zietz Annaelle, Polymeris Alexandros A, Traenka Christopher, Thilemann Sebastian, Wagner Benjamin, Altersberger Valerian L, Piot Ines, Barinka Filip, Hänsel Martin, Gensicke Henrik, Engelter Stefan T, Lyrer Philippe A, Sutter Raoul, Nickel Christian H, Katan Mira, Peters Nils, Michels Lars, Kulcsar Zsolt, Karwacki Grzegorz M, Pileggi Marco, Cereda Carlo W, Wegener Susanne, Bonati Leo H, Fischer Urs, Psychogios Marios-Nikos, De Marchis Gian Marco

Zitation

Dittrich T, Sporns P, Kriemler L, Rudin S, Nguyen A, Zietz A, Polymeris A, Traenka C, Thilemann S, Wagner B, Altersberger V, Piot I, Barinka F, Hänsel M, Gensicke H, Engelter S, Lyrer P, Sutter R, Nickel C, Katan M, Peters N, Michels L, Kulcsar Z, Karwacki G, Pileggi M, Cereda C, Wegener S, Bonati L, Fischer U, Psychogios M, De Marchis G. Mechanical thrombectomy for large vessel occlusion between 6 and 24 h: outcome comparison of DEFUSE-3/DAWN eligible versus non-eligible patients. Int J Stroke 2022; 18:697-703.

Art

Wissenschaftlicher Artikel/Review (Englisch)

Zeitschrift

Int J Stroke 2022; 18

Veröffentlichungsdatum

14.12.2022

eISSN (Online)

1747-4949

Seiten

697-703

Kurzbeschreibung/Zielsetzung

The DEFUSE-3 and DAWN trials showed that mechanical thrombectomy (MT) improves the outcome of selected patients with anterior circulation large vessel occlusions (LVO) up to 24 h after stroke onset. However, it is unknown whether only those patients fulfilling the trial inclusion criteria benefit, or whether benefit is seen in a broader range of patients presenting between 6 and 24 h.